The deal, announced Monday in a
The deal values Amedisys at about $3.29 billion, based on the company’s share count. Shares of Amedisys were little changed at the US market open. Shares of Option Care rose 3.2% at ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.